Sg3 Management, LLC Amphastar Pharmaceuticals, Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $83,970 - $113,760	-3,000 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$27.56 - $37.75 $82,680 - $113,250	3,000 New	3,000 $84,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $1.3 Million - $1.77 Million	-47,000 Reduced 94.0%	3,000 $84,000
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $1.49 Million - $2.11 Million	50,000 New	50,000 $1.74 Million

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.